Galapagos NV
NASDAQ:GLPG

  • LAST PRICE
    27.6400
  • TODAY'S CHANGE (%)
    -0.4800 (-1.7070%)
  • Bid / Lots
    26.8200/ 1
  • Ask / Lots
    28.4300/ 1
  • Open / Previous Close
    27.8700 / 28.1200
  • Day Range
    27.6200
    27.9300
  • 52 Week Range
    24.1600
    42.4550
  • Volume
    54,795

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 5, 2024

      Show headlines and story abstract

    • 4:01PM ET on Tuesday Nov 05, 2024 by Dow Jones
      Companies Mentioned: GLPG

      Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024
      -- New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in addressing unmet needs for patients with poor prognoses. -- Our innovative decentralized cell therapy manufacturing platform delivers fresh, fit cells within a median vein-to-vein time of seven days, with potentially encouraging patient outcomes. -- Three abstracts, including one oral presentation for GLPG5101 in relapsed/refractory non-Hodgkin lymphoma, and a company showcase, will spotlight our cutting-edge cell therapy innovations in blood cancers and solid tumors.

  • Nov 1, 2024

  • Oct 30, 2024

      Show headlines and story abstract

    • 4:20PM ET on Wednesday Oct 30, 2024 by Dow Jones
      Companies Mentioned: GLPG

    • 4:01PM ET on Wednesday Oct 30, 2024 by Dow Jones
      Companies Mentioned: GLPG
      ---------------------------------------------- ----------- -----------
      Consolidated statements of changes in equity (unaudited)
      Share (thousands of Share premium Translation Other Accumulated EUR) capital account differences reserves losses Total -------------- ------- --------- ----------- -------- ----------- --------- On January 1, 2023 293,604 2,735,557 (1,593) (4,853) (496,689) 2,526,026 -------------- ------- --------- ----------- -------- ----------- --------- Net profit 54,138 54,138 -------------- ------- --------- ----------- -------- ----------- --------- Other comprehensive income/loss (-) 397 (79) 318 -------------- ------- --------- ----------- -------- ----------- --------- Total comprehensive income/loss (-) 397 (79) 54,138 54,456 -------------- ------- --------- ----------- -------- ----------- --------- Share-based compensation 39,308 39,308 -------------- ------- --------- ----------- -------- ----------- --------- Exercise of subscription rights 333 1,437 1,770 -------------- ------- --------- ----------- -------- ----------- --------- On September 30, 2023 293,937 2,736,994 (1,196) (4,932) (403,242) 2,621,560 -------------- ------- --------- ----------- -------- ----------- --------- On January 1, 2024 293,937 2,736,994 (1,201) (5,890) (228,274) 2,795,566 -------------- ------- --------- ----------- -------- ----------- --------- Net profit 48,775 48,775 -------------- ------- --------- ----------- -------- ----------- --------- Other comprehensive income/loss (-) 4,329 (1,151) 3,178 -------------- ------- --------- ----------- -------- ----------- --------- Total comprehensive income/loss (-) 4,329 (1,151) 48,775 51,953 -------------- ------- --------- ----------- -------- ----------- --------- Share-based compensation 15,051 15,051 -------------- ------- --------- ----------- -------- ----------- --------- On September 30, 2024 293,937 2,736,994 3,128 (7,041) (164,448) 2,862,570 -------------- ------- --------- ----------- -------- ----------- ---------

Peers Headlines